secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-10-05T21:00:41+00:00
Accession:  0001213900-26-106872
Event type: debt
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Tessera Defense adds $5M Mandragola convertible credit line at 12%, issues 2.69M shares to lender
--------------------------------------------------------------------------------

- New $5,000,000 revolving line of credit from Mandragola Ltd. (Israel) signed Oct. 5, 2026; runs alongside, and does not replace, the prior $2,000,000 May 13, 2026 line.
- Advances bear 12% simple interest, mature Oct. 5, 2029, and convert at the lower of the 5-day lowest NYSE American close or $1.00 per share; 19.99% exchange cap pending stockholder approval.
- Issued 2,690,500 restricted shares to Mandragola between Sept. 29 and Oct. 2, 2026: 200,000 on conversion of a $95,020 note at $0.4751 per share.
- Remaining 2,490,500 shares came in four tranches from cashless exercises of the DFSL warrant issued to Mandragola on April 13, 2026 (60% DFSL stake acquisition).
- Company had 8,920,240 shares outstanding as of Oct. 2, 2026 after these issuances and ATM sales; no advances drawn under the new line yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026106872/0001213900-26-106872-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026106872/ea0307709-8k_tessera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-106872

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer